Skip to main content
SpringerLink
Log in

Intragastric ethanol infusion model for cellular and molecular studies of alcoholic liver disease

  • Review
  • Published:
Journal of Biomedical Science

Abstract

The intragastric alcohol infusion rat model (IAIRM) of alcoholic liver disease (ALD) has been utilized in various laboratories to study various aspects of ALD pathogenesis including oxidative stress, cytokine upregulation, hypoxic damage, apoptosis, ubiquitin-proteasome pathway and CYP2E 1 induction. The basic value of the model is that it produces pathologic changes which resemble ALD including microvesicular and macrovesicular fat, megamitochondria, apoptosis, central lobular and pericellular fibrosis, portal fibrosis, bridging fibrosis, central necrosis, and mixed inflammatory infiltrate including PMNs and lymphocytes. The model is valuable because the diet and ethanol intake are totally under the control of the investigator. A steady state can be maintained with high or low blood alcohol levels for long periods. The cycling of the blood alcohol levels, when a constant infusion rate of alcohol is maintained, simulates binge drinking. Using this model the importance of dietary fat, especially the degree of saturation of the fatty acids on the induction of liver pathology, has been documented. The role of endotoxin, the Kupffer cell, TNFα, and NADPH oxidase have been demonstrated. The importance of 2E1 in oxidative stress induction has been shown using inhibitors of the isozyme. The importance of dietary iron in the pathogenesis of cirrhosis has been documented. Acetaldehyde has been shown to play a role in preventing liver pathology by preventing NFκB activation. Using the model, to maintain high blood alcohol levels is found to be necessary to demonstrate proteasomal peptidase inhibition. Ubiquitin synthesis is also inhibited at high blood alcohol levels in the IAIRM model. Oxidized proteins accumulate in the liver at high blood alcohol levels. Neoantigens derived from protein adducts formed with products of oxidation induce autoimmune mechanisms of liver injury. Thus, in many ways the model has revolutionized our understanding of the pathogenesis of ALD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Albano E, Clot P, Morimoto M, Tamasi A, Ingelman-Sundberg M, French SW. Role of cytochrome P450 2E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol. Hepatology 23:155–163;1996.

    PubMed  Google Scholar 

  2. Albano E, French SW, Ingelman-Sundberg M. Hydroxyethyl radicals in ethanol hepatotoxicity. Front Biosci 4:d533-d540;1999.

    PubMed  Google Scholar 

  3. Badger TM, Ronis MJJ, Ingelman-Sundberg M, Hakkak R. Pulsatile blood alcohol and CYP2E1 induction during chronic alcohol infusion in rats. Alcohol 10:453–457;1993.

    Article  Google Scholar 

  4. Banenjee A, Kocarek TA, Novak RF. Identification of a ubiquitination-target/substrate-interaction domain of cytochrome P-450 (CYP)2E1. Drug Metab Dispos 28:118–124;2000.

    PubMed  Google Scholar 

  5. Cederbaum AI. Toxicity of ethanol in HEPG2 cells expressing CYP2E1. Alcohol Clin Exp Res 24:165A;2000.

  6. Donohue TM Jr, Zetterman RK, Zhang-Gouillon ZQ, French SW. Peptidase activities of the multicatalytic proteasome in rat liver after voluntary and intragastric ethanol administration. Hepatology 28:486–491;1998.

    Article  PubMed  Google Scholar 

  7. Eng FJ, Friedman SF. Fibrogenesis. I. New insights into hepatic stellate cell activation: The simple becomes complex. Am J Physiol 279:G7-G11;2000.

    Google Scholar 

  8. Enomoto N, Ikejima K, Yamashima S, Enomoto A, Nishiura T, Nishimura T, Brenner DA, Schemmer P, Bradford BU, Rivera CA, Zhong Z, Thurman RG. Kupffer cell-derived prostaglandin E2 is involved in alcohol-induced fat accumulation in rat liver. Am J Physiol Gastrointest Liver Physiol 279:G100-G106;2000.

    PubMed  Google Scholar 

  9. Fataccioli V, Andraud E, Gentil M, French SW, Rouach H. Effects of chronic ethanol administration on rat liver proteasome activities. Hepatology 29:14–20;1999.

    Article  PubMed  Google Scholar 

  10. French BA, Li J, Bardag-Gorce F, Wan Y-J, French SW. Hypoxic-reperfusion liver injury in an alcohol binge drinking rat model (abstract, ASLD Meeting). Hepatology 31:2000.

  11. French SW. Mechanisms of alcoholic liver injury. Can J Gastroenterol 14:327–332;2000.

    PubMed  Google Scholar 

  12. French SW. The ubiquitin-proteasome 26s pathway in liver cell protein turnover. Effect of ethanol and drugs. Alcohol Clin Exp Res 24(suppl):169A;2000.

  13. French SW, Benson NC, Sun PS. Centrilobular liver necrosis induced by hypoxia in chronic ethanol-fed rats. Hepatology 4:912–917;1984.

    PubMed  Google Scholar 

  14. French SW, Kim W, Jui L, Albano E, Hagbjork A-L, Ingelman-Sundberg M. Effect of ethanol on cytochrome P450 2E1 (CYP2E1) lipid peroxidation and serum protein adduct formation in relation to liver pathology pathogenesis. Exp Mol Pathol 58:61–75;1993.

    Article  PubMed  Google Scholar 

  15. French SW, Miyamoto K, Ohta Y, Geoffrion Y. Pathogenesis of experimental liver disease in the rat. Methods Achiev Exp Pathol 13:181–207;1988.

    PubMed  Google Scholar 

  16. French SW, Miyamoto K, Tsukamoto H. Ethanol-induced hepatic fibrosis in the rat. Role of the amount of dietary fat. Alcohol Clin Exp Res 10:13s-19s;1986.

    PubMed  Google Scholar 

  17. French SW, Miyamoto K, Wong K, Jui L, Briere L. Role of the Ito cell in liver parenchymal fibrosis in rats fed alcohol and a high fatlow protein diet. Am J Pathol 132:73–85;1988.

    PubMed  Google Scholar 

  18. French SW, Morimoto M, Reitz R, Koop D, Klopfenstein B, Estes K, Clot P, Ingelman-Sundberg M, Albano E. Lipid peroxidation, CYP2E1, and fatty acid metabolism in alcoholic liver disease. J Nutr 127:9075–9115;1997.

    Google Scholar 

  19. French SW, Morimoto M, Reitz R, Koop D, Klopfenstein B, Estes K, Clot P, Ingelman-Sundberg M, Albano E. Lipid peroxidation, CYP2E1, and fatty acid metabolism in alcoholic liver disease. J Nutr 127:9075–9115;1997.

    Google Scholar 

  20. French SW, Zhang-Gouillon ZQ, Ingelman-Sundberg M. The role of CYP2E1 induction by ethanol in the pathogenesis of alcoholic liver disease as determined by inhibitors of CYP2E1 transcription and post translational modulating factors. Alcohol Clin Exp Res 22:738–739;1998.

    PubMed  Google Scholar 

  21. Gouillon Z-Q, Lucas D, Li J, Hagbjork Al, French BA, Fu P, Fang C, Ingelman-Sundberg M, Donohue TM Jr, French SW. Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole. Proc Soc Exp Biol Med 224:302–308;2000.

    PubMed  Google Scholar 

  22. Gouillon ZQ, Miyamoto K, Donohue TM, Wan Y-Y, French BA, Nagao Y, Fu P, Reitz RC, Hagbjork A-L, Yap C, Ingelman-Sundberg M, French SW. Role of CYP2E1 in the pathogenesis of alcoholic liver disease: Modifications by cAMP and ubiquitin-proteasome pathway. Front Biosci 4:16–25;1999.

    Google Scholar 

  23. Kono H, Bradford BU, Yin M, Sulik K, Koop DR, Peters JM, Gonzalez FJ, McDonald TA, Dikolova A, Kadiiska MB, Mason RP, Thurman RG. CYP2E1 is not involved in early alcohol-induced liver injury. Am J Physiol 277:G1259-G1267;1999.

    PubMed  Google Scholar 

  24. Koop DR, Klopfenstein B, Ilmuro Y, Thurman RG. Gadolinium chloride blocks alcohol-dependent liver toxicity in rats treated chronically with intragastric alcohol despite induction of CYP2E1. Mol Pharmacol 51:944–950;1997.

    PubMed  Google Scholar 

  25. Lands WEM. Cellular signals in alcohol-induced liver injury: A review. Alcohol Clin Exp Res 19:928–938;1995.

    PubMed  Google Scholar 

  26. Li J, Nguyen V, French BA, Parlow AF, Su GL, Fu P, Yuan QX, French SW. Mechanism of the cyclic pattern of urinary ethanol levels in rats fed ethanol. The role of the hypothalamic-pituitary-thyroid axis. Am J Physiol 279:G118–125;2000.

    Google Scholar 

  27. Lindros KO, Jokelanen K, Nanji AA. Acetaldehyde prevents nuclear factor-kappa B activation and hepatic inflammation in ethanol-fed rats. Lab Invest 79:799–806;1999.

    PubMed  Google Scholar 

  28. Lytton SD, Helander A, Zhang-Gouillon Z-Q, Stokkeland K, Bordone R, Arico S, Albano E, French SW, Ingelman-Sundberg M. Autoantibodies against cytochrome P450 2E1 and P-4503A in alcoholics. Mol Pharmacol 55:223–233;1999.

    PubMed  Google Scholar 

  29. Miyamoto K, French SW. Hepatic adenine nucleotide metabolism measured in vivo in rats fed ethanol and a high fat-low protein diet: Relation to the pathogenesis of alcohol-induced liver injury in the rat. Hepatology 8:53–60;1988a.

    PubMed  Google Scholar 

  30. Miyamoto K, French SW. Hepatic adenosine in rats fed ethanol: Effect of acute hyperoxia or hypoxia. Alcohol Clin Exp Res 12:512–515;1988.

    PubMed  Google Scholar 

  31. Morimoto M, Hagbjork A-L, Nanji AA, Fu P, Ingelman-Sundberg M, Lindros KO, Albano E, French SW. Role of cytochrome P450 2E1 in alcoholic liver disease pathogenesis. Alcohol 10:459–464;1993.

    Article  PubMed  Google Scholar 

  32. Morimoto M, Hagbjork A-L, Wan Y-JY, Fu P, Clot P. Modulation of experimental alcoholic liver disease by cytochrome P450 2E1 inhibitors. Hepatology 21:1610–1617;1995.

    Article  PubMed  Google Scholar 

  33. Morimoto M, Reitz RC, Morin RJ, Nguyen K, Ingelman-Sundberg M, French SW. Fatty acid composition in hepatic lipids in rats fed ethanol and high fat diet intragastrically. Effect of CYP2E1 inhibitors. J Nutr 125:2953–2964;1995.

    PubMed  Google Scholar 

  34. Morimoto M, Zern MA, Hagbjork A-L, Ingelman-Sundberg M, French SW. Fish oil, alcohol and liver pathology: Role of cytochrome P450 2E1. Proc Soc Exp Biol Med 207:197–205;1994.

    PubMed  Google Scholar 

  35. Nanji AA, French SW. Dietary linoleic acid is required for development of experimental alcoholic liver disease. Life Sci 44:223–227;1989.

    Article  PubMed  Google Scholar 

  36. Nanji AA, Jokelanainen K, Rahemtulla A, Miao L, Fogt F, Mtsumoto H, Tahan SR, Su GL. Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 30:934–943;1999.

    Article  PubMed  Google Scholar 

  37. Nanji AA, Jui LT, French SW. Effect of chronic carbon monoxide exposure on progression of experimental alcoholic liver injury. Life Sci 45:885–890;1989.

    Article  PubMed  Google Scholar 

  38. Nanji AA, Khettry U, Sadrzadeh SMH. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver disease. Proc Soc Exp Biol Med 205:243–247;1994.

    PubMed  Google Scholar 

  39. Nanjo AA, Khettry V, Sadrzadeh SMH, Yamanaka T. Severity of liver injury in experimental alcoholic liver disease: Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4 and thromboxane B2. Am J Pathol 142:367–373;1993.

    PubMed  Google Scholar 

  40. Nanji AA, Mendenhall CL, French SW. Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res 13:15–19;1989.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Harbor-UCLA Medical Center, 1000 W. Carson Street, 90509, Torrance, CA, USA

    Samuel W. French MD

Authors
  1. Samuel W. French MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

French, S.W. Intragastric ethanol infusion model for cellular and molecular studies of alcoholic liver disease. J Biomed Sci 8, 20–27 (2001). https://doi.org/10.1007/BF02255967

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02255967

Key Words

Search

Navigation